RESUMEN
Sarcocystis spp. cause pigeon protozoan encephalitis, a neuronal disease. A female pigeon exhibiting torticollis had a necrotic area in the cerebral hemisphere surrounded by lesions with perivascular cuffing, gliosis, granulomatous foci, and meningitis. Non-necrotic lesions were also observed in the brainstem. Intact and degenerative schizonts were observed within the neuropils and neurons in the lesions. Deoxyribonucleic acid (DNA) was extracted from paraffin-embedded brain tissues and genetically analyzed after gel electrophoresis to determine Sarcocystis spp. using specific primer sets for 28S ribosomal ribonucleic acid and internal transcribed spacer region-1. DNA sequencing confirmed a significant homology with S. calchasi. This is the first report of meningoencephalitis with malacia caused by S. calchasi in a rock pigeon in Japan.
Asunto(s)
Enfermedades de las Aves , Columbidae , Meningoencefalitis , Sarcocystis , Sarcocistosis , Animales , Sarcocystis/aislamiento & purificación , Sarcocystis/genética , Columbidae/parasitología , Sarcocistosis/veterinaria , Sarcocistosis/parasitología , Sarcocistosis/patología , Femenino , Japón , Enfermedades de las Aves/parasitología , Enfermedades de las Aves/patología , Meningoencefalitis/veterinaria , Meningoencefalitis/parasitología , Meningoencefalitis/patología , Encéfalo/patología , Encéfalo/parasitologíaRESUMEN
Neonatal meningoencephalitis caused by human parechovirus infection is being increasingly recognized in recent literature. While most cases are postnatally acquired, intrauterine infection is rare, presents early and has a more severe impact on brain health and development. We discuss here an infant born preterm at 34 weeks gestational age, with neonatal course remarkable for severe encephalopathy presenting on day 2 of life due to human parechovirus meningoencephalitis transmitted in utero. Early magnetic resonance brain imaging detected extensive white matter injury and subsequently evolved into multicystic leukoencephalopathy. Posthospital discharge, infant was noted to have early neurodevelopmental impairment at 4 months corrected age.
Asunto(s)
Meningoencefalitis , Parechovirus , Infecciones por Picornaviridae , Humanos , Recién Nacido , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Recien Nacido Prematuro , Imagen por Resonancia Magnética/métodos , Meningoencefalitis/diagnóstico por imagen , Meningoencefalitis/patología , Neuroimagen , Infecciones por Picornaviridae/diagnóstico , Infecciones por Picornaviridae/patologíaRESUMEN
Viral nervous necrosis (viral encephalopathy and retinopathy) is caused by piscine nodavirus (Nodaviridae, Betanodavirus). Since 1986, this highly infectious virus has caused mass mortalities of up to 100% in farmed saltwater and freshwater fish around the world (with the exception of South America and Antarctica), affecting >60 species across 10 orders. The Atlantic blue marlin (Makaira nigricans Lacépède, 1802) is a top-level predator found throughout the tropical waters of the Atlantic and Indo-Pacific oceans. Despite their popularity as a sportfish, relatively little is known about the Atlantic blue marlin and other billfish. We describe here chronic betanodavirus infection in a juvenile Atlantic blue marlin, which is, to our knowledge, the first report of disease in M. nigricans.
Asunto(s)
Enfermedades de los Peces , Meningoencefalitis , Nodaviridae , Animales , Enfermedades de los Peces/virología , Enfermedades de los Peces/patología , Meningoencefalitis/veterinaria , Meningoencefalitis/virología , Meningoencefalitis/patología , Infecciones por Mononegavirales/veterinaria , Infecciones por Mononegavirales/virología , Infecciones por Mononegavirales/patología , Nodaviridae/aislamiento & purificación , Perciformes/virologíaRESUMEN
Anti-glial fibrillary acidic protein (GFAP) meningoencephalomyelitis (autoimmune GFAP astrocytopathy) is a new autoimmune central nervous system (CNS) disease diagnosable by the presence of anti-GFAP autoantibodies in the cerebrospinal fluid and presents as meningoencephalomyelitis in the majority of patients. Only few neuropathological reports are available and little is known about the pathogenic mechanisms. We performed a histopathological study of two autopsies and nine CNS biopsies of patients with anti-GFAP autoantibodies and found predominantly a lymphocytic and in one autopsy case a granulomatous inflammatory phenotype. Inflammatory infiltrates were composed of B and T cells, including tissue-resident memory T cells. Although obvious astrocytic damage was absent in the GFAP-staining, we found cytotoxic T cell-mediated reactions reflected by the presence of CD8+/perforin+/granzyme A/B+ cells, polarized towards astrocytes. MHC-class-I was upregulated in reactive astrocytes of all biopsies and two autopsies but not in healthy controls. Importantly, we observed a prominent immunoreactivity of astrocytes with the complement factor C4d. Finally, we provided insight into an early phase of GFAP autoimmunity in an autopsy of a pug dog encephalitis that was characterized by marked meningoencephalitis with selective astrocytic damage with loss of GFAP and AQP4 in the lesions.Our histopathological findings indicate that a cytotoxic T cell-mediated immune reaction is present in GFAP autoimmunity. Complement C4d deposition on astrocytes could either represent the cause or consequence of astrocytic reactivity. Selective astrocytic damage is prominent in the early phase of GFAP autoimmunity in a canine autopsy case, but mild or absent in subacute and chronic stages in human disease, probably due to the high regeneration potential of astrocytes. The lymphocytic and granulomatous phenotypes might reflect different stages of lesion development or patient-specific modifications of the immune response. Future studies will be necessary to investigate possible implications of pathological subtypes for clinical disease course and therapeutic strategies.
Asunto(s)
Enfermedades Autoinmunes del Sistema Nervioso , Encefalomielitis , Meningoencefalitis , Humanos , Animales , Perros , Proteína Ácida Fibrilar de la Glía/metabolismo , Encefalomielitis/patología , Astrocitos/patología , Enfermedades Autoinmunes del Sistema Nervioso/líquido cefalorraquídeo , Enfermedades Autoinmunes del Sistema Nervioso/terapia , Meningoencefalitis/líquido cefalorraquídeo , Meningoencefalitis/patología , AutoanticuerposRESUMEN
Cryptococcus neoformans, an opportunistic fungal pathogen, primarily infects immunodeficient patients frequently causing cryptococcal meningoencephalitis (CM). Increased intracranial pressure (ICP) is a serious complication responsible for increased morbidity and mortality in CM patients. Non-invasive pharmacological agents that mitigate ICP could be beneficial in treating CM patients. The objective of the study was to investigate the efficacy of acetazolamide (AZA), candesartan (CAN), and triciribine (TCBN), in combination with the antifungal fluconazole, on C. neoformans-induced endothelial, brain, and lung injury in an experimental mouse model of CM. Our study shows that C. neoformans increases the expression of brain endothelial cell (BEC) junction proteins Claudin-5 (Cldn5) and VE-Cadherin to induce pathological cell-barrier remodeling and gap formation associated with increased Akt and p38 MAPK activation. All three agents inhibited C. neoformans-induced endothelial gap formation, only CAN and TCBN significantly reduced C. neoformans-induced Cldn5 expression, and only TCBN was effective in inhibiting Akt and p38MAPK. Interestingly, although C. neoformans did not cause brain or lung edema in mice, it induced lung and brain injuries, which were significantly reversed by AZA, CAN, or TCBN. Our study provides novel insights into the direct effects of C. neoformans on BECs in vitro, and the potential benefits of using AZA, CAN, or TCBN in the management of CM patients.
Asunto(s)
Cryptococcus neoformans , Meningitis Criptocócica , Meningoencefalitis , Humanos , Animales , Ratones , Fluconazol/farmacología , Fluconazol/uso terapéutico , Meningitis Criptocócica/tratamiento farmacológico , Meningitis Criptocócica/microbiología , Acetazolamida/uso terapéutico , Proteínas Proto-Oncogénicas c-akt , Antifúngicos/farmacología , Antifúngicos/uso terapéutico , Meningoencefalitis/tratamiento farmacológico , Meningoencefalitis/microbiología , Meningoencefalitis/patologíaRESUMEN
Cryptococcal meningoencephalitis (CM), caused by the fungal pathogen Cryptococcus neoformans species complex, can lead to high mortality or severe neurological sequelae in survivors that are associated with excessive inflammation in the central nervous system (CNS), especially in those who develop immune reconstitution inflammatory syndrome (IRIS) or postinfectious immune response syndrome (PIIRS). While the means to establish a cause-and-effect relationship of a specific pathogenic immune pathway during CM by human studies are limited, mouse models allow dissection of the potential mechanistic links within the CNS immunological network. In particular, these models are useful for separating pathways contributing predominantly to immunopathology from those important for fungal clearance. In this protocol, we described methods to induce a robust, physiologically relevant murine model of C. neoformans CNS infection that reproduces multiple aspects of human cryptococcal disease immunopathology and subsequent detailed immunological analysis. Combined with tools including gene knockout mice, antibody blockade, cell adoptive transfer, as well as high throughput techniques such as single-cell RNA sequencing, studies using this model will provide new insights regarding the cellular and molecular processes that elucidate the pathogenesis of cryptococcal CNS diseases in order to develop more effective therapeutic strategies.
Asunto(s)
Criptococosis , Cryptococcus neoformans , Meningoencefalitis , Humanos , Animales , Ratones , Modelos Animales de Enfermedad , Meningoencefalitis/microbiología , Meningoencefalitis/patología , Sistema Nervioso Central/patologíaRESUMEN
A deceased 9-wk-old male gray fox (Urocyon cinereoargenteus) with a history of decreased ambulation and diarrhea was submitted to the Texas A&M Veterinary Medical Diagnostic Laboratory. No significant gross findings were evident on postmortem examination. Histologically, the cerebrum and brainstem had mild necrotizing meningoencephalitis with protozoal schizonts and merozoites. Additionally, glial cells contained intracytoplasmic and intranuclear viral inclusion bodies. Sections of the cerebrum were positive for canine distemper virus (CDV) and negative for Sarcocystis neurona on immunohistochemistry. Bayesian analysis revealed that this Sarcocystis sp. clustered most closely with a clade of unnamed Sarcocystis sp. found in viperid snakes, with a posterior probability of 99%. CDV likely played a significant role in the expression of clinical sarcocystosis in this gray fox.
Asunto(s)
Virus del Moquillo Canino , Moquillo , Enfermedades de los Perros , Meningoencefalitis , Sarcocystis , Sarcocistosis , Masculino , Animales , Perros , Zorros , Teorema de Bayes , Meningoencefalitis/veterinaria , Meningoencefalitis/patología , Sarcocistosis/diagnóstico , Sarcocistosis/veterinaria , Sarcocistosis/patologíaRESUMEN
BACKGROUND/AIM: Tau is a microtubule-associated protein involved in the assembly and stabilization of microtubules. In human medicine, hyperphosphorylation of tau is associated with microtubule instability and is considered to play a role in the progression of multiple sclerosis (MS). MS is an autoimmune neurological disease that shares many characteristics, including pathological mechanisms, with canine meningoencephalitis of unknown etiology (MUE). With this background, this study investigated the presence of hyperphosphorylated tau in dogs with MUE and experimental autoimmune encephalomyelitis (EAE). MATERIALS AND METHODS: In total, eight brain samples were examined from two neurologically normal dogs, three dogs with MUE, and three canine EAE models. Anti-(phospho-S396) tau antibody was used for immunohisto-chemistry, which stained hyperphosphorylated tau. RESULTS: In normal brain tissues, hyperphosphorylated tau was not found. In all the dogs with EAE and one of the dogs with MUE, immunoreactivity for S396 p-tau was observed in glial cell cytoplasm and the background in the periphery of the inflammatory lesion. CONCLUSION: These results suggest for the first time that tau pathology may be involved in the progression of neuroinflammation in dogs, similar to that in human MS.
Asunto(s)
Meningoencefalitis , Esclerosis Múltiple , Animales , Perros , Encéfalo/patología , Meningoencefalitis/veterinaria , Meningoencefalitis/metabolismo , Meningoencefalitis/patología , Microtúbulos/metabolismo , Fosforilación , Proteínas tau/metabolismoRESUMEN
Mammaliicoccus (Staphylococcus) sciuri has been rarely associated with infections and sepsis in humans. A 3-month-old male western lowland gorilla (Gorilla gorilla gorilla), born under human care, died after a traumatic event. Histologic, microbiologic, and molecular findings in postmortem demonstrated a suppurative meningoencephalitis and bacteremia associated with M. sciuri infection.
Asunto(s)
Bacteriemia , Meningoencefalitis , Animales , Masculino , Humanos , Gorilla gorilla , Meningoencefalitis/diagnóstico , Meningoencefalitis/veterinaria , Meningoencefalitis/patología , Staphylococcus , Bacteriemia/diagnóstico , Bacteriemia/veterinariaAsunto(s)
Eosinófilos/patología , Meningoencefalitis/diagnóstico , Neuroesquistosomiasis/diagnóstico , Adulto , Ataxia/etiología , Tronco Encefálico/diagnóstico por imagen , Tronco Encefálico/patología , Diagnóstico Diferencial , Imagen de Difusión por Resonancia Magnética , Femenino , Trastornos Neurológicos de la Marcha/etiología , Humanos , Imagen por Resonancia Magnética , Meningoencefalitis/diagnóstico por imagen , Meningoencefalitis/patología , Neuroesquistosomiasis/diagnóstico por imagen , Neuroesquistosomiasis/patología , Paresia/etiologíaRESUMEN
Primary varicella infection has typical cutaneous lesions which aid in clinical diagnosis. Infants with transplacental transfer of varicella antibody can have varied cutaneous lesions. We report a 4-month-old infant with primary varicella meningoencephalitis without cutaneous lesions whose mother had no history of varicella during antenatal or post-natal period. Diagnosis was made possible by CSF DNA PCR. Infants with encephalitis pose diagnostic challenge to clinicians in resource limited settings. Varicella encephalitis is one such aetiology for which definitive therapy with Acyclovir is available. CSF PCR is the definitive and cost-effective test for the diagnosis varicella encephalitis. In children with meningoencephalitis it is prudent to add Acyclovir empirically pending CSF viral PCR results.
Asunto(s)
Varicela , Meningoencefalitis , Antivirales/uso terapéutico , Varicela/complicaciones , Varicela/diagnóstico , Varicela/tratamiento farmacológico , Niño , ADN Viral/uso terapéutico , Femenino , Herpesvirus Humano 3/genética , Humanos , Lactante , Meningoencefalitis/diagnóstico , Meningoencefalitis/tratamiento farmacológico , Meningoencefalitis/patología , EmbarazoRESUMEN
We are reporting two patients of fatal and rapidly progressive amoebic encephalitis in immunocompetent host from poor socioeconomic status. Both these patient had acute neurological worsening preoperatively and did not respond to subsequent surgical decompression. Biopsy report confirmed acanthamoebic cerebral infection.
Asunto(s)
Amebiasis , Meningoencefalitis , Amebiasis/diagnóstico , Amebiasis/patología , Humanos , Meningoencefalitis/patologíaRESUMEN
BACKGROUND AND OBJECTIVES: To describe the autopsy findings and neuropathologic evaluation of autoimmune meningoencephalomyelitis associated with glial fibrillary acidic protein (GFAP) antibody. METHODS: We reviewed the clinical course, imaging, laboratory, and autopsy findings of a patient with autoimmune meningoencephalomyelitis associated with GFAP antibody who had a refractory course to multiple immunosuppressive therapies. RESULTS: The patient was a 70-year-old man who was diagnosed as GFAP antibody-associated autoimmune meningoencephalomyelitis. MRI of the head showed linear perivascular enhancement in the midbrain and the basal ganglia. Despite treatment with high-dose corticosteroids, plasma exchange, IV immunoglobulins, and cyclophosphamide, he died with devastating neurologic complications. Autopsy revealed a coexistent neuroendocrine tumor in the small intestine and diffuse inflammation in the brain parenchyma, perivascular spaces, and leptomeninges, with predominant T-cells, macrophages, and activated microglia. B-cells and plasma cells were absent. There was no astrocyte involvement with change in GFAP immunostaining. DISCUSSION: This case illustrates autoimmune meningoencephalomyelitis associated with GFAP antibody in the CSF and coexistent neuroendocrine tumor. The autopsy findings were nonspecific and did not demonstrate astrocyte involvement. Further accumulation of cases is warranted to delineate the utility and pathogenic significance of the GFAP autoantibody.
Asunto(s)
Enfermedades Autoinmunes del Sistema Nervioso , Proteína Ácida Fibrilar de la Glía/inmunología , Meningoencefalitis , Tumores Neuroendocrinos , Anciano , Enfermedades Autoinmunes del Sistema Nervioso/diagnóstico , Enfermedades Autoinmunes del Sistema Nervioso/inmunología , Enfermedades Autoinmunes del Sistema Nervioso/patología , Autopsia , Encefalomielitis/diagnóstico , Encefalomielitis/inmunología , Encefalomielitis/patología , Humanos , Masculino , Meningoencefalitis/diagnóstico , Meningoencefalitis/inmunología , Meningoencefalitis/patología , Tumores Neuroendocrinos/diagnóstico , Tumores Neuroendocrinos/inmunología , Tumores Neuroendocrinos/patologíaRESUMEN
Zika virus (ZIKV) is a mosquito-borne neurotropic flavivirus. ZIKV infection may lead to microcephaly in developing fetus and Guillain-Barré Syndrome (GBS) like symptoms in adults. ZIKV was first reported in humans in 1952 from Uganda and the United Republic of Tanzania. Later, ZIKV outbreak was reported in 2007 from the Yap Island. ZIKV re-emerged as major outbreak in the year 2013 from French Polynesia followed by second outbreak in the year 2015 from Brazil. ZIKV crosses the blood-tissue barriers to enter immune-privileged organs. Clinical manifestations in ZIKV disease includes rash, fever, conjunctivitis, muscle and joint pain, headache, transverse myelitis, meningoencephalitis, Acute Disseminated Encephalomyelitis (ADEM). The understanding of the molecular mechanism of ZIKV pathogenesis is very important to develop potential diagnostic and therapeutic interventions for ZIKV infected patients.
Asunto(s)
Encefalomielitis Aguda Diseminada/virología , Meningoencefalitis/virología , Infección por el Virus Zika/patología , Infección por el Virus Zika/transmisión , Virus Zika/inmunología , Animales , Culicidae/virología , Encefalomielitis Aguda Diseminada/patología , Femenino , Humanos , Transmisión Vertical de Enfermedad Infecciosa , Meningoencefalitis/patología , Placenta/virología , Embarazo , Enfermedades Transmitidas por Vectores/virología , Virus Zika/crecimiento & desarrollo , Virus Zika/patogenicidadRESUMEN
Cryptococcal meningoencephalitis was first described over a century ago. This fungal infection is preventable and treatable yet continues to be associated with excessive morbidity and mortality. The largest burden of disease resides in people living with HIV in low-income and middle-income countries. In this group, mortality with the best antifungal induction regimen (7 days of amphotericin B deoxycholate [1·0 mg/kg per day] and flucytosine [100·0 mg/kg per day]) in a clinical trial setting was 24% at 10 weeks. The world is now at an inflection point in terms of recognition, research, and action to address the burden of morbidity and mortality from cryptococcal meningoencephalitis. However, the scope of interventional programmes needs to increase, with particular attention to implementation science that is specific to individual countries. This Review summarises causes of excessive mortality, interventions with proven survival benefit, and gaps in knowledge and practice that contribute to the ongoing high death toll from cryptococcal meningoencephalitis. TRANSLATIONS: For the Vietnamese and Chichewa translations of the abstract see Supplementary Materials section.
Asunto(s)
Antifúngicos/uso terapéutico , Criptococosis , Meningoencefalitis/tratamiento farmacológico , Meningoencefalitis/mortalidad , Anfotericina B , Bases de Datos Factuales , Ácido Desoxicólico , Combinación de Medicamentos , Quimioterapia Combinada , Fluconazol , Flucitosina/farmacología , Flucitosina/uso terapéutico , Humanos , Meningoencefalitis/microbiología , Meningoencefalitis/patologíaRESUMEN
Myelin oligodendrocyte glycoprotein (MOG) antibodies have been found in a broad range of demyelination diseases. In the present study, we reported three cases of patients with anti-MOG antibodies associated disorders (MOG-ADs) who initially presented as intracranial infection like encephalomeningitis with no evidence of demyelination injury, but were subsequently found the expression of MOG antibodies and other demyelination presentations. Our findings suggested that MOG-ADs can start as an intracranial infection like prodromal symptoms prior to the lesions of optic nerve, spinal cord, and white matter. Therefore, clinicians should be cautious of MOG-ADs in cases of encephalomeningitis even without demyelination injury.
Asunto(s)
Enfermedades Autoinmunes Desmielinizantes SNC/inmunología , Enfermedades Autoinmunes Desmielinizantes SNC/patología , Meningoencefalitis/inmunología , Glicoproteína Mielina-Oligodendrócito/inmunología , Adolescente , Adulto , Autoanticuerpos/inmunología , Autoantígenos/inmunología , Femenino , Humanos , Masculino , Meningoencefalitis/patología , Adulto JovenAsunto(s)
Citrobacter freundii/aislamiento & purificación , Enfermedades de los Peces/microbiología , Meningoencefalitis/veterinaria , Absceso/veterinaria , Animales , Infecciones por Enterobacteriaceae/veterinaria , Masculino , Meningoencefalitis/microbiología , Meningoencefalitis/patología , Sepsis/veterinaria , TiburonesRESUMEN
Immune-mediated encephalitis as an adverse event due to checkpoint inhibitors is very rare. We describe herein the case of a 38-year-old woman with metastatic triple-negative breast cancer who developed seizures and somnolence twelve days after receiving the first dose of Atezolizumab. Work up ruled out all infectious etiologies, and the patient was eventually diagnosed with immune-mediated meningoencephalitis. Symptoms recovered with a high-dose of steroids, and she was found to have an excellent response on follow-up imaging, which raised the question of whether a relationship exists between the occurrence, and severity of the adverse event and the response to treatment. Only a few other cases of atezolizumab-related encephalitis have been published. Early recognition and treatment are crucial; the reason why we are describing this case along with a review of the literature and a review on all the neurological immune-related adverse events due to the different checkpoint inhibitors.
Asunto(s)
Humanos , Femenino , Adulto , Adenocarcinoma , Neoplasias de la Mama Triple Negativas/patología , Antineoplásicos Inmunológicos/efectos adversos , Meningoencefalitis/patología , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Inmunoterapia/efectos adversos , Manifestaciones NeurológicasRESUMEN
A 12-y-old spayed female Schipperke dog with a previous diagnosis of inflammatory bowel disease was presented with a 2-mo history of severe colitis. The patient's condition progressed to hepatopathy, pneumonia, and dermatitis following management with prednisolone and dexamethasone sodium phosphate. Colonic biopsies identified severe necrosuppurative colitis with free and intracellular parasitic zoites. Postmortem examination confirmed extensive chronic-active ulcerative colitis, severe acute necrotizing hepatitis and splenitis, interstitial pneumonia, ulcerative dermatitis, myelitis (bone marrow), and mild meningoencephalitis with variable numbers of intracellular and extracellular protozoal zoites. PCR on samples of fresh colon was positive for Neospora caninum. Immunohistochemistry identified N. caninum tachyzoites in sections of colon, and a single tissue cyst in sections of brain. Administration of immunosuppressive drugs may have allowed systemic dissemination of Neospora from the intestinal tract.
Asunto(s)
Coccidiosis/veterinaria , Colitis Ulcerosa/veterinaria , Enfermedades de los Perros/diagnóstico , Inmunohistoquímica/veterinaria , Neospora/aislamiento & purificación , Animales , Coccidiosis/diagnóstico , Coccidiosis/patología , Colitis Ulcerosa/parasitología , Colitis Ulcerosa/patología , Dermatitis/parasitología , Dermatitis/patología , Dermatitis/veterinaria , Enfermedades de los Perros/etiología , Enfermedades de los Perros/parasitología , Enfermedades de los Perros/patología , Perros , Femenino , Hepatitis Animal/parasitología , Hepatitis Animal/patología , Meningoencefalitis/parasitología , Meningoencefalitis/patología , Meningoencefalitis/veterinaria , Mielitis/parasitología , Mielitis/patología , Mielitis/veterinaria , Neospora/patogenicidad , Neumonía/parasitología , Neumonía/patología , Neumonía/veterinaria , Reacción en Cadena de la Polimerasa/veterinaria , Enfermedades del Bazo/parasitología , Enfermedades del Bazo/patología , Enfermedades del Bazo/veterinariaRESUMEN
Cryptococcal meningoencephalitis (CM) is the major cause of infection-related neurological death, typically seen in immunocompromised patients. However, T cell-driven inflammatory response has been increasingly implicated in lethal central nervous system (CNS) immunopathology in human patients and murine models. Here, we report marked up-regulation of the chemokine receptor CXCR3 axis in human patients and mice with CM. CXCR3 deletion in mice improves survival, diminishes neurological deficits, and limits neuronal damage without suppressing fungal clearance. CD4+ T cell accumulation and TH1 skewing are reduced in the CNS but not spleens of infected CXCR3-/- mice. Adoptive transfer of WT, but not CXCR3-/- CD4+ T cells, into CXCR3-/- mice phenocopies the pathology of infected WT mice. Collectively, we found that CXCR3+CD4+ T cells drive lethal CNS pathology but are not required for fungal clearance during CM. The CXCR3 pathway shows potential as a therapeutic target or for biomarker discovery to limit CNS inflammatory damages.